{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T20:45:12Z","timestamp":1746218712466,"version":"3.40.4"},"reference-count":14,"publisher":"BMJ","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ Case Reports"],"abstract":"<jats:p>The use of treatment with antipsychotic drugs highlights the difficulty of finding the right balance between the benefit on psychotic symptoms and the risk of the occurrence of adverse reactions. There is a strong genetic and pharmacological evidence supporting the hypothesis that activation of D2 receptors could lead to hypothermia and that the treatment haloperidol is capable of inducing hypothermia apomorfino similarily in laboratory animals. It also seems that, haloperidol is not the only antipsychotic able to determine this type of reaction, as some evidence suggests that other drugs such as reserpine, chlorpromazine would be capable of inducing hypothermia. Finally, while some studies suggest the possible occurrence of haloperidol-induced hypothermia only in laboratory animals, other authors argue that this same reaction can occur in humans as well. In this report, we describe the cases, rarely witnessed in the literature, of three patients in whom the administration of haloperidol caused hypothermia.<\/jats:p>","DOI":"10.1136\/bcr-2013-200321","type":"journal-article","created":{"date-parts":[[2013,9,19]],"date-time":"2013-09-19T11:40:52Z","timestamp":1379590852000},"page":"bcr2013200321","source":"Crossref","is-referenced-by-count":4,"title":["What about temperature? Haloperidol-induced hypotermia"],"prefix":"10.1136","volume":"2013","author":[{"given":"Maria Salvina","family":"Signorelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Nalis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariacatena","family":"Battiato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenio","family":"Aguglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2013,9,19]]},"reference":[{"key":"2025042709195397000_2013.sep19_1.bcr2013200321.1","first-page":"617","article-title":"Adverse effects of antipsychotic medications","volume":"2013","author":"Muench","year":"2010","journal-title":"Am Fam Physician"},{"key":"2025042709195397000_2013.sep19_1.bcr2013200321.2","unstructured":"Baldessarini RJ . Drugs acting on the central nervous system. Goodman Gilman's Textbook on Pharmacology. 11th edn. USA: McGraw Hill Publishers, 2006;317\u201399."},{"key":"2025042709195397000_2013.sep19_1.bcr2013200321.3","first-page":"745","article-title":"Neuroleptic-induced hypothermia in mice: lack of evidence for a central mechanism","volume":"2013","author":"Boschi","year":"1987","journal-title":"J Pharmac"},{"key":"2025042709195397000_2013.sep19_1.bcr2013200321.4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1043-6618(03)00108-7","article-title":"Possible involvement of opioid receptors in moclobemide-induced hypothermia in mice","volume":"2013","author":"Ginawi","year":"2003","journal-title":"Pharmacol Res"},{"key":"2025042709195397000_2013.sep19_1.bcr2013200321.5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.mrgentox.2009.04.011","article-title":"Species-level differences between mice and rats in regards to micronucleus induction with the hypothermia-inducing drug haloperidol","volume":"2013","author":"Asanami","year":"2009","journal-title":"Mutat Res"},{"key":"2025042709195397000_2013.sep19_1.bcr2013200321.6","first-page":"595","article-title":"A schizophrenic patient who developed extreme hypothermia after an increase in the dose of haloperidol: a case report","volume":"2013","author":"Harada","year":"1994","journal-title":"Jpn J Psychiatry Neurol"},{"key":"2025042709195397000_2013.sep19_1.bcr2013200321.7","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.medin.2011.12.005","article-title":"Management of severe accidental hypothermia","volume":"2013","author":"Avellanas","year":"2012","journal-title":"Med Intensiva"},{"key":"2025042709195397000_2013.sep19_1.bcr2013200321.8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1556\/OH.2011.29006","article-title":"Physiologic effects of hypothermia","volume":"2013","author":"Kov\u00e1cs","year":"2011","journal-title":"Orv Hetil"},{"key":"2025042709195397000_2013.sep19_1.bcr2013200321.9","doi-asserted-by":"crossref","first-page":"e27673","DOI":"10.1371\/journal.pone.0027673","article-title":"Design, synthesis, and pharmacological evaluation of haloperidol derivatives as novel potent calcium channel blockers with vasodilator activity","volume":"2013","author":"Chen","year":"2011","journal-title":"PLoS ONE"},{"key":"2025042709195397000_2013.sep19_1.bcr2013200321.10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0163-7258(01)00139-5","article-title":"Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs","volume":"2013","author":"Joyce","year":"2001","journal-title":"Pharmacol Ther"},{"key":"2025042709195397000_2013.sep19_1.bcr2013200321.11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00023210-200418010-00003","article-title":"Role of dopamine receptor agonists in the treatment of restless legs syndrome","volume":"2013","author":"Happe","year":"2004","journal-title":"CNS Drugs"},{"key":"2025042709195397000_2013.sep19_1.bcr2013200321.12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00213-007-0766-3","article-title":"Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists","volume":"2013","author":"Collins","year":"2007","journal-title":"Psychopharmacology"},{"key":"2025042709195397000_2013.sep19_1.bcr2013200321.13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0149-7634(79)90010-1","article-title":"Changes in body temperature after administration of amino acids, peptides, dopamine, neuroleptics and related agents","volume":"2013","author":"Clark","year":"1979","journal-title":"Neurosci Biobehav Rev"},{"key":"2025042709195397000_2013.sep19_1.bcr2013200321.14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0149-7634(85)90052-1","article-title":"Changes in body temperature after administration of amino acids, pep- tides, dopamine, neuroleptics and related agents: I","volume":"2013","author":"Clark","year":"1985","journal-title":"Neurosci Biobehav Rev"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2013-200321","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T16:20:01Z","timestamp":1745770801000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2013-200321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,19]]},"references-count":14,"alternative-id":["10.1136\/bcr-2013-200321"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2013-200321","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2013,9,19]]}}}